ESC: CURRENT-OASIS 7 misses primary endpoint, but high dose ...
ESC: CURRENT-OASIS 7 misses primary endpoint, but high dose clopidogrel aids PCI ... presented results of the CURRENT-OASIS 7 (Clopidogrel Optimal Loading Dose Usage ...

CURRENT OASIS 7 PCI analysis
Doubling the dose of clopidogrel reduced the risk of MI and stent thrombosis in ... CURRENT OASIS-7: Benefit to doubling clopidogrel dose in ACS patients undergoing ...

CURRENT OASIS 7: A 2X2 Factorial Randomized Trial of
CURRENT OASIS 7 was funded by a grant from sanofi-aventis and ... PCI, using double-dose clopidogrel for 7 days. instead of standard dose will. prevent an ...

OASIS-7/CURRENT
CURRENT study overview ... the CURRENT-OASIS 7 (Clopidogrel optimal loading dose Usage to Reduce Recurrent ... and rationale of CURRENT-OASIS 7: a randomized, 2 ...

CURRENT OASIS-7: Doubling clopidogrel dosing has favorable ...
CURRENT OASIS-7: Doubling clopidogrel dosing has favorable net clinical benefit' ... anticipated findings from CURRENT OASIS-7 (Clopidogrel optimal loading Dose ...

Doubling clopidogrel dose in ACS
The CURRENT OASIS-7 study is a 2x2 factorial, randomized trial studying the ... CURRENT OASIS-7: Benefit to doubling clopidogrel dose in ACS patients undergoing ...

InCirculation.net - cardiovascular medicine resources ...
CURRENT OASIS-7: Doubling clopidogrel dosing has favorable net clinical benefit' 30 August 2009 ... findings from CURRENT OASIS-7 (Clopidogrel optimal loading ...

Publication in the American Heart Journal of CURRENT-OASIS 7 ...
CURRENT-OASIS 7 (Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent ... "CURRENT-OASIS 7 will provide critical information on whether the effects of a ...

CURRENT/ OASIS 7
Acute Coronary Syndrome. Current/Oasis 7. A Phase III, randomized, multinational, ... Administration of clopidogrel > 300 mg within 24 hours prior to ...

For Heart Patients Undergoing Angioplasty, Double Doses Of ...
... presented results of the CURRENT-OASIS 7 (Clopidogrel Optimal Loading Dose Usage ... The CURRENT-OASIS 7 study was sponsored by Sanofi-Aventis and Bristol-Myers ...

current oasis 7 clopidogrel, coffee vs tea caffeine, profits from ibuprofen, symptoms of too much caffeine, atorvastatin cns, how long adjust synthroid, tricor pravachol zocor paxil, uvula minocycline, testosterone syndrone by shippman, orlistat vs allie, antidepressant abilify